Molecular genetics of cutaneous squamous cell carcinoma: perspective for treatment strategies
Lucia Di Nardo(Università Cattolica del Sacro Cuore), Ketty Peris(Università Cattolica del Sacro Cuore), Alfredo Piccerillo(Università Cattolica del Sacro Cuore), Laura Del Regno(Agostino Gemelli University Polyclinic), Cristina Pellegrini(University of L'Aquila), Claus Garbe(University of Tübingen), Pietro Sollena(Università Cattolica del Sacro Cuore), Maria Concetta Fargnoli(University of L'Aquila), Alessandro Di Stefani(University of Rome Tor Vergata), Caterina Longo(Istituto Giannina Gaslini)
Cited by 58
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
|New England Journal of Medicine|2019|1.4k